Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge E Cortes

Showing results (1-10 of 417) with videos related to

Pageof 42
Sort By:
Clinical Advances in Hematology & Oncology : H&O|December 29, 2025
What is the role of asciminib in chronic myeloid leukemia?Jorge E Cortes
Future Oncology (London, England)|May 31, 2013
A journey searching for a cure for leukemia. Interviewed by Natasha GalukandeJorge E Cortes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2011
Not only response but early response to tyrosine kinase inhibitors in chronic myeloid leukemiaJorge E Cortes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2008
Imatinib therapy for chronic myeloid leukemia: where do we go now?Jorge E Cortes
Blood Advances|December 28, 2018
A second-generation TKI should always be used as initial therapy for CMLJorge E Cortes
Expert Review of Hematology|May 15, 2024
Olutasidenib: a novel mutant IDH1 inhibitor for the treatment of relapsed or refractory acute myeloid leukemiaJorge E Cortes
American Journal of Hematology|December 28, 2020
Determination of fitness and therapeutic options in older patients with acute myeloid leukemiaJorge E Cortes, Priyanka Mehta
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2017
Reply to K.R. HoffmanJorge E Cortes, Andreas Hochhaus
International Journal of Hematology|July 9, 2004
Imatinib mesylate in the treatment of chronic myelogenous leukemiaGautam Borthakur, Jorge E Cortes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2014
Complete cytogenetic response, not deep molecular response, is associated with survival in chronic myeloid leukemiaHagop Kantarjian, Jorge E Cortes
Pageof 42

Showing results (1-10 of 417) with videos related to

Sort By:
Pageof 42
Clinical Advances in Hematology & Oncology : H&O|December 29, 2025
What is the role of asciminib in chronic myeloid leukemia?Jorge E Cortes
Future Oncology (London, England)|May 31, 2013
A journey searching for a cure for leukemia. Interviewed by Natasha GalukandeJorge E Cortes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2011
Not only response but early response to tyrosine kinase inhibitors in chronic myeloid leukemiaJorge E Cortes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2008
Imatinib therapy for chronic myeloid leukemia: where do we go now?Jorge E Cortes
Blood Advances|December 28, 2018
A second-generation TKI should always be used as initial therapy for CMLJorge E Cortes
Expert Review of Hematology|May 15, 2024
Olutasidenib: a novel mutant IDH1 inhibitor for the treatment of relapsed or refractory acute myeloid leukemiaJorge E Cortes
American Journal of Hematology|December 28, 2020
Determination of fitness and therapeutic options in older patients with acute myeloid leukemiaJorge E Cortes, Priyanka Mehta
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2017
Reply to K.R. HoffmanJorge E Cortes, Andreas Hochhaus
International Journal of Hematology|July 9, 2004
Imatinib mesylate in the treatment of chronic myelogenous leukemiaGautam Borthakur, Jorge E Cortes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2014
Complete cytogenetic response, not deep molecular response, is associated with survival in chronic myeloid leukemiaHagop Kantarjian, Jorge E Cortes
Pageof 42